Haemonetics announces Q4 and FY2024 financial results; details not available in this filing

HAEMONETICS CORP

2024-FY EPS reported $2.29 revenue$1,309,055,000

Press release dated May 9, 2024, reports results for quarter and fiscal year ended March 30, 2024.
Specific financial figures (EPS, revenue, guidance) are not included in the provided filing text.
The release may contain material operational updates, but cannot be summarized without exhibit content.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HAEMONETICS CORP reported financial results for the fourth quarter and fiscal year ended March 30, 2024.

Period: the fourth quarter and fiscal year ended March 30, 2024
Result: reported results

Exact text from the filing

Item 2.02 Results of Operations and Financial Condition. On May 9, 2024 , Haemonetics Corporation issued a press release announcing financial results for the fourth quarter and fiscal year ended March 30, 2024.

View on SEC.gov

1050 earnings releases filed in the last 30 days. Browse all earnings releases →

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-24-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.